Page last updated: 2024-11-05

benzoylacetone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Benzoylacetone, also known as 1-phenyl-1,3-butanedione, is a beta-diketone compound with a significant role in organic chemistry and coordination chemistry. Benzoylacetone exhibits keto-enol tautomerism, existing in both keto and enol forms. The enol form is favored, leading to a resonance-stabilized structure.

Benzoylacetone is a versatile reagent, playing a key role in various reactions, including:

- **Metal complex formation:** It acts as a bidentate ligand, forming stable complexes with various metal ions like Cu(II), Ni(II), and Fe(III). These complexes are investigated for their potential applications in catalysis, magnetic materials, and biological systems.
- **Organic synthesis:** Benzoylacetone serves as a building block in the synthesis of diverse organic compounds. It undergoes various reactions, including aldol condensation, Michael addition, and Claisen condensation, enabling the construction of complex molecules.
- **Dye synthesis:** Benzoylacetone derivatives are used as intermediates in the production of azo dyes, which find applications in textile, printing, and food industries.

Benzoylacetone exhibits antibacterial, antifungal, and antioxidant properties. Its biological activities are attributed to its ability to chelate metal ions and to act as a free radical scavenger. Further research aims to explore its potential as a therapeutic agent.

Benzoylacetone is synthesized by the Claisen condensation reaction between ethyl benzoate and acetone, using a strong base catalyst.

In summary, benzoylacetone is a valuable compound studied for its diverse chemical properties, including its ability to form stable metal complexes, act as a building block in organic synthesis, and exhibit biological activities.'

Cross-References

ID SourceID
PubMed CID7166
CHEMBL ID3186793
SCHEMBL ID15116
MeSH IDM0109587

Synonyms (72)

Synonym
nsc-83580
nsc-97232
nsc-100655
nsc-83581
nsc-87898
nsc100655
nsc-97233
nsc-88942
.alpha.-acetylacetophenone
93-91-4
benzoylacetone
2-propanone, benzoyl-
acetylbenzoylmethane
nsc4015
nsc-4015
2-acetylacetophenone
acetoacetophenone
1-phenyl-1,3-butanedione
1-benzoyl-2-propanone
1-benzoylacetone
alpha-acetylacetophenone
benzoyl-aceton [german]
brn 0742413
ai3-10572
einecs 202-286-4
nsc 4015
nsc-405722
nsc-405723
nsc-405724
nsc-404283
1,3-butanedione, 1-phenyl-
1-phenylbutane-1,3-dione
inchi=1/c10h10o2/c1-8(11)7-10(12)9-5-3-2-4-6-9/h2-6h,7h2,1h
1-phenyl-1,3-butanedione, 99%
B-0690
STK802149
AKOS000119529
(z)-4-hydroxy-4-phenyl-but-3-en-2-one;1-phenyl-1,3-butanedione
A844735
dtxsid3021803 ,
tox21_202879
cas-93-91-4
dtxcid901803
NCGC00260425-01
1-phenyl-butane-1,3-dione
4-07-00-02151 (beilstein handbook reference)
unii-i3ruv8u115
benzoyl-aceton
i3ruv8u115 ,
FT-0622746
4-oxo-4-phenylbutan-2-one
1-methyl-3-phenyl-1,3-propanedione
4-phenyl-2,4-butanedione
phenyl-1,3-butanedione, 1-
1-phenylbutan-1,3-dione
SCHEMBL15116
PS-3611
benzoyl acetone
acetyl acetophenone
1-phenyl-1,3-butandione
1-phenyl-butane-1,3 dione
STR01075
CHEMBL3186793
F3098-2657
J-802021
mfcd00008786
1-phenyl-1,3-butanedione, purum, >=98.0% (gc)
EN300-19842
CS-W014323
Q27280358
SY011141
HY-W013607

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"A new method of single-drop microextraction combined with low-temperature electrothermal vaporization (LTETV)-ICPMS was proposed for the determination of trace Be, Co, Pd, and Cd with benzoylacetone (BZA) as both extractant and chemical modifier."( Single-drop microextraction combined with low-temperature electrothermal vaporization ICPMS for the determination of trace Be, Co, Pd, and Cd in biological samples.
Hu, B; Jiang, Z; Liang, Y; Wu, Y; Xia, L, 2004
)
0.51

Dosage Studied

ExcerptRelevanceReference
"A rapid, sensitive and selective spectrophotometric method has been developed for the quantitative determination of dapsone (DAP) and metoclopramide hydrochloride (MCP) in both pure and dosage forms."( Individual and simultaneous spectrophotometric determination of dapsone and metoclopramide HCl in pharmaceutical dosage forms and synthetic binary mixtures.
Omran, AA, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (4)

PathwayProteinsCompounds
isopropanol biosynthesis (engineered)528
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation1855
pyruvate fermentation to acetone529
superpathway of Clostridium acetobutylicum solventogenic fermentation1444

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency6.90080.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency69.00830.000714.592883.7951AID1259369
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency10.93710.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency21.82240.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency33.49270.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency5.52910.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency44.09820.001530.607315,848.9004AID1224841; AID1224842; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency61.50380.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency34.58610.000229.305416,493.5996AID743079
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency22.01160.001019.414170.9645AID743094
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency30.82490.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency69.00830.001628.015177.1139AID1259385
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency34.88610.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency99.48220.039147.5451146.8240AID1224845; AID1224896
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.53)18.7374
1990's2 (10.53)18.2507
2000's9 (47.37)29.6817
2010's4 (21.05)24.3611
2020's2 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.27 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index44.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]